Trifluoperazine

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 3645 Experts worldwide ranked by ideXlab platform

Leite, Renner De Souza - One of the best experts on this subject based on the ideXlab platform.

  • Efeito de uma fosfolipase A2 Lisina 49, ACL miotoxina, do veneno da serpente Agkistrodon contortrix laticinctus sobre o transpote de água em bexiga urinária isolada de sapo.
    Programa de Pós-graduação em Ciências Fisiológicas, 2004
    Co-Authors: Leite, Renner De Souza
    Abstract:

    ACL myotoxin (ACLMT) is a Lys49 phospholipase A2-like protein isolated from the venom of the snake Agkistrodon contortrix laticinctus. The aim of this work was to study the effect of ACLMT on water transport in the toad urinary bladder. Water flow through the membrane was measured gravimetrically in bag preparations of the bladder. ACLMT increased the baseline water flow and partially inhibited the water permeability stimulated by arginine-vasopressin (AVP), cyclic AMP, 8-chlorophenylthio-cAMP and forskolin. The effect of ACLMT on baseline water flow was prevented by lanthanum, nifedipine, and Trifluoperazine. These results suggest that the effect of ACLMT on baseline water flow could be mediated either by an increase in intracellular calcium or by the activation of the calcium-calmodulin. Colchicine reduced the effect of ACLMT on baseline water permeability. Carbachol has been shown to enhance baseline water flow while inhibiting AVP-stimulated water flow by increase in intracellular calcium. The effects of ACLMT and carbachol on baseline and AVP-stimulated water flow were not additive, suggesting that both agents alter the water transport by a similar mechanism. Lanthanum reduced the inhibitory effect of ACLMT on AVP-stimulated water permeability, suggesting the participation of intracellular calcium in this effect. Indomethacin reduced the effect of ACLMT on forskolinstimulated water flow, suggesting a role for prostaglandin in the effect of ACLMT on AVP-stimulated water permeability. However, the inhibitory effect of ACLMT on AVP-stimulated water flow was enhanced in the presence of Trifluoperazine. Similarly, the inhibitory effect of ACLMT on AVP and cAMP-stimulated water flow was enhanced in the presence of colchicine. Therefore, the results of present study suggest that the effects of ACLMT on water permeability could be mediated either by an increase in intracellular calcium or by the activation of the calciumcalmodulin, and also suggests a role additional for prostaglandin in effect of ACLMT on AVP-stimulated water transport. In addition, the effect of ACLMT on water transport seems be dependent of integrity of microtubules.Universidade Federal de Minas GeraisACL miotoxina (ACLMT) é uma fosfolipase A2 miotóxica com um resíduo de lisina na posição 49, isolada do veneno da serpente Agkistrodon contortrix laticinctus. O objetivo do presente trabalho foi estudar o efeito da ACLMT sobre o transporte de água em bexiga de sapo. O fluxo de água através da membrana foi mensurado gravimetricamente por meio da técnica de Bentley (1958), em preparações com a bexiga em forma de lobos. A ACLMT aumentou o fluxo basal de água e diminuiu parcialmente o fluxo de água estimulado pela vasopressina, AMP cíclico, 8-clorofeniltiomonofosfato de adenosina cíclico e forscolina. O efeito da ACLMT sobre o fluxo basal de água foi reduzido na presença de lanthanum, nifedipina e trifluoperazina, sugerindo um papel para o cálcio citossólico e para o complexo cálcio-calmodulina nesse efeito. A colchicina também diminuiu o efeito da ACLMT sobre o fluxo basal de água, sugerindo que a ação da ACLMT é dependente da integridade dos microtúbulos. O lantânio reduziu o efeito inibitório da ACLMT sobre a ação hidrosmótica da vasopressina, sugerindo um papel para o cálcio citossólico nesse efeito. O carbacol é capaz de aumentar o fluxo basal de água e diminuir o fluxo de água estimulado pela vasopressina por meio de um aumento da concentração do cálcio intracelular. Os efeitos da ACLMT e do carbacol sobre o transporte de água não foram aditivos, sugerindo que esses agentes alteram a permeabilidade da membrana por um mecanismo similar. A indometacina reduziu o efeito da ACLMT sobre o fluxo de água estimulado pela forscolina, sugerindo um papel adicional para as prostaglandinas no efeito da ACLMT sobre a ação da vasopressina. Por outro lado, o efeito inibitório da ACLMT sobre a ação hidrosmótica da vasopressina foi potencializado na presença de trifluoperazina. Similarmente, o efeito inibitório da ACLMT sobre a ação hidrosmótica da vasopressina e do AMP cíclico foi potencializado na presença da colchicina. Nossos resultados sugerem que o efeito da ACLMT sobre o transporte de água pode ser mediado pelo aumento no cálcio intracelular e pela ativação do complexo cálcio-calmodulina, sugerindo também um papel adicional para as prostaglandinas no efeito da ACLMT sobre a ação hidrosmótica da vasopressina. Além disso, o efeito da ACLMT sobre o transporte de água parece ser dependente da integridade dos microtúbulos

Renner De Souza Leite - One of the best experts on this subject based on the ideXlab platform.

  • Efeito de uma fosfolipase A2 Lisina 49, ACL miotoxina, do veneno da serpente Agkistrodon contortrix laticinctus sobre o transpote de água em bexiga urinária isolada de sapo.
    Universidade Federal de São Carlos, 2004
    Co-Authors: Renner De Souza Leite
    Abstract:

    ACL miotoxina (ACLMT) é uma fosfolipase A2 miotóxica com um resíduo de lisina na posição 49, isolada do veneno da serpente Agkistrodon contortrix laticinctus. O objetivo do presente trabalho foi estudar o efeito da ACLMT sobre o transporte de água em bexiga de sapo. O fluxo de água através da membrana foi mensurado gravimetricamente por meio da técnica de Bentley (1958), em preparações com a bexiga em forma de lobos. A ACLMT aumentou o fluxo basal de água e diminuiu parcialmente o fluxo de água estimulado pela vasopressina, AMP cíclico, 8-clorofeniltiomonofosfato de adenosina cíclico e forscolina. O efeito da ACLMT sobre o fluxo basal de água foi reduzido na presença de lanthanum, nifedipina e trifluoperazina, sugerindo um papel para o cálcio citossólico e para o complexo cálcio-calmodulina nesse efeito. A colchicina também diminuiu o efeito da ACLMT sobre o fluxo basal de água, sugerindo que a ação da ACLMT é dependente da integridade dos microtúbulos. O lantânio reduziu o efeito inibitório da ACLMT sobre a ação hidrosmótica da vasopressina, sugerindo um papel para o cálcio citossólico nesse efeito. O carbacol é capaz de aumentar o fluxo basal de água e diminuir o fluxo de água estimulado pela vasopressina por meio de um aumento da concentração do cálcio intracelular. Os efeitos da ACLMT e do carbacol sobre o transporte de água não foram aditivos, sugerindo que esses agentes alteram a permeabilidade da membrana por um mecanismo similar. A indometacina reduziu o efeito da ACLMT sobre o fluxo de água estimulado pela forscolina, sugerindo um papel adicional para as prostaglandinas no efeito da ACLMT sobre a ação da vasopressina. Por outro lado, o efeito inibitório da ACLMT sobre a ação hidrosmótica da vasopressina foi potencializado na presença de trifluoperazina. Similarmente, o efeito inibitório da ACLMT sobre a ação hidrosmótica da vasopressina e do AMP cíclico foi potencializado na presença da colchicina. Nossos resultados sugerem que o efeito da ACLMT sobre o transporte de água pode ser mediado pelo aumento no cálcio intracelular e pela ativação do complexo cálcio-calmodulina, sugerindo também um papel adicional para as prostaglandinas no efeito da ACLMT sobre a ação hidrosmótica da vasopressina. Além disso, o efeito da ACLMT sobre o transporte de água parece ser dependente da integridade dos microtúbulos.ACL myotoxin (ACLMT) is a Lys49 phospholipase A2-like protein isolated from the venom of the snake Agkistrodon contortrix laticinctus. The aim of this work was to study the effect of ACLMT on water transport in the toad urinary bladder. Water flow through the membrane was measured gravimetrically in bag preparations of the bladder. ACLMT increased the baseline water flow and partially inhibited the water permeability stimulated by arginine-vasopressin (AVP), cyclic AMP, 8-chlorophenylthio-cAMP and forskolin. The effect of ACLMT on baseline water flow was prevented by lanthanum, nifedipine, and Trifluoperazine. These results suggest that the effect of ACLMT on baseline water flow could be mediated either by an increase in intracellular calcium or by the activation of the calcium-calmodulin. Colchicine reduced the effect of ACLMT on baseline water permeability. Carbachol has been shown to enhance baseline water flow while inhibiting AVP-stimulated water flow by increase in intracellular calcium. The effects of ACLMT and carbachol on baseline and AVP-stimulated water flow were not additive, suggesting that both agents alter the water transport by a similar mechanism. Lanthanum reduced the inhibitory effect of ACLMT on AVP-stimulated water permeability, suggesting the participation of intracellular calcium in this effect. Indomethacin reduced the effect of ACLMT on forskolinstimulated water flow, suggesting a role for prostaglandin in the effect of ACLMT on AVP-stimulated water permeability. However, the inhibitory effect of ACLMT on AVP-stimulated water flow was enhanced in the presence of Trifluoperazine. Similarly, the inhibitory effect of ACLMT on AVP and cAMP-stimulated water flow was enhanced in the presence of colchicine. Therefore, the results of present study suggest that the effects of ACLMT on water permeability could be mediated either by an increase in intracellular calcium or by the activation of the calciumcalmodulin, and also suggests a role additional for prostaglandin in effect of ACLMT on AVP-stimulated water transport. In addition, the effect of ACLMT on water transport seems be dependent of integrity of microtubules

E J Morcillo - One of the best experts on this subject based on the ideXlab platform.

  • calcium antagonist properties of cinnarizine Trifluoperazine and verapamil in guinea pig normal and skinned trachealis muscle
    Journal of Pharmacy and Pharmacology, 2011
    Co-Authors: Julio Cortijo, R.w. Foster, R C Small, E J Morcillo
    Abstract:

    In guinea-pig trachealis, depolarized by a K(+)-rich medium, Ca2+ (0.01-10 mM) caused concentration-related spasm. Verapamil (0.5-5 microM), cinnarizine (10-100 microM) and Trifluoperazine (16-160 microM) each produced concentration-dependent antagonism of Ca2+ characterized by a rightward and downward displacement of the log concentration-effect curve for Ca2+. The rank order of potencies of these antagonists, measured as the IC75 against Ca2+ (10 mM)-induced contraction of depolarized trachea, was verapamil (5.6 microM) greater than cinnarizine (59 microM) greater than Trifluoperazine (91 microM). In skinned trachea, verapamil in concentrations up to 100 microM did not modify the concentration-effect curve for Ca2+. In contrast, cinnarizine (59-177 microM) diminished the sensitivity and Trifluoperazine (273 microM) decreased the responsiveness of the tissue to Ca2+. In skinned trachea, Trifluoperazine (91 microM) produced greater inhibition of Ca2+ (10 microM)-induced contraction after 120 min than after 30 min of incubation. Verapamil (100 microM) and cinnarizine (177 microM) were devoid of inhibitory effect against the 10 microM Ca2+ standard. In skinned trachea, changes in the Ca2+ concentration-effect curve produced by cinnarizine (177 microM) were reversed after washout whilst those induced by Trifluoperazine (273 microM) persisted. It is concluded that distinct differences exist between the three calcium antagonists examined. The action of verapamil is restricted to the plasmalemma. That of cinnarizine and Trifluoperazine is exerted both on the plasma membrane and upon the intracellular contractile machinery.

Zaijie Jim Wang - One of the best experts on this subject based on the ideXlab platform.

  • reversal of chronic inflammatory pain by acute inhibition of ca2 calmodulin dependent protein kinase ii
    Journal of Pharmacology and Experimental Therapeutics, 2008
    Co-Authors: Fang Luo, Lei Tang, Pradeep Kumar Shukla, Cheng Yang, Yan Chen, Lili X Wang, Zaijie Jim Wang
    Abstract:

    Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) is a major protein kinase that is capable of regulating the activities of many ion channels and receptors. In the present study, the role of CaMKII in the complete Freund's adjuvant (CFA)-induced inflammatory pain was investigated. Intraplantarly injected CFA was found to induce spinal activity of CaMKII (phosphorylated CaMKII), which was blocked by KN93 [[2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine)], a CaMKII inhibitor. Pretreatment with KN93 (i.t.) dose-dependently prevented the development of CFA-induced thermal hyperalgesia and mechanical allodynia. Acute treatment with KN93 (i.t.) also dose-dependently reversed CFA-induced thermal hyperalgesia and mechanical allodynia. The action of KN93 started in 30 min and lasted for at least 2 to 4 h. KN92 (45 nmol i.t.) [2-[N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine], an inactive analog of KN93, showed no effect on CFA-induced CaMKII activation, allodynia, or hyperalgesia. Furthermore, our previous studies identified Trifluoperazine, a clinically used antipsychotic drug, to be a potent CaMKII inhibitor. Inhibition of CaMKII activity by Trifluoperazine was confirmed in the study. In addition, Trifluoperazine (i.p.) dose-dependently reversed CFA-induced mechanical allodynia and thermal hyperalgesia. The drug was also effectively when given orally. In conclusion, our findings support a critical role of CaMKII in inflammatory pain. Blocking CaMKII or CaMKII-mediated signaling may offer a novel therapeutic target for the treatment of chronic pain.

  • Trifluoperazine an orally available clinically used drug disrupts opioid antinociceptive tolerance
    Neuroscience Letters, 2006
    Co-Authors: Lei Tang, Pradeep Kumar Shukla, Zaijie Jim Wang
    Abstract:

    Calcium/calmodulin dependent protein kinase II (CaMKII) has been shown to play an important role in the generation and maintenance of opioid tolerance. In this study, Trifluoperazine was studied for its effect on morphine tolerance in mice. Acute treatment with Trifluoperazine (0.5 mg/kg, i.p.) completely reversed the established antinociceptive tolerance to morphine. Pretreatment with Trifluoperazine also significantly attenuated the development of antinociceptive tolerance (p<0.01). Morphine induced a significant up-regulation of supraspinal and spinal CaMKII activity in tolerant mice, which was abolished after the pretreatment or acute treatment with Trifluoperazine. These data suggested that Trifluoperazine was capable of suppressing opioid tolerance, possibly by the mechanism of inhibiting CaMKII. Since Trifluoperazine has been safely used as an antipsychotic drug, we propose that the drug should be studied in humans for the prevention and treatment of opioid tolerance and addiction.

Sergei Doulatov - One of the best experts on this subject based on the ideXlab platform.

  • calmodulin inhibitors improve erythropoiesis in diamond blackfan anemia
    Science Translational Medicine, 2020
    Co-Authors: Alison M Taylor, Elizabeth R Macari, Iris T Chan, Megan C Blair, Sergei Doulatov
    Abstract:

    Diamond-Blackfan anemia (DBA) is a rare hematopoietic disease characterized by a block in red cell differentiation. Most DBA cases are caused by mutations in ribosomal proteins and characterized by higher than normal activity of the tumor suppressor p53. Higher p53 activity is thought to contribute to DBA phenotypes by inducing apoptosis during red blood cell differentiation. Currently, there are few therapies available for patients with DBA. We performed a chemical screen using zebrafish ribosomal small subunit protein 29 (rps29) mutant embryos that have a p53-dependent anemia and identified calmodulin inhibitors that rescued the phenotype. Our studies demonstrated that calmodulin inhibitors attenuated p53 protein amount and activity. Treatment with calmodulin inhibitors led to decreased p53 translation and accumulation but does not affect p53 stability. A U.S. Food and Drug Administration-approved calmodulin inhibitor, Trifluoperazine, rescued hematopoietic phenotypes of DBA models in vivo in zebrafish and mouse models. In addition, Trifluoperazine rescued these phenotypes in human CD34+ hematopoietic stem and progenitor cells. Erythroid differentiation was also improved in CD34+ cells isolated from a patient with DBA. This work uncovers a potential avenue of therapeutic development for patients with DBA.